Clinical Trials

10,000 enrolled

Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Extranodal NK-T-Cell

NCT05073250 2023-05-12

IBI376 Plus Rituximab in Patients With Untreated Indolent Lymphoma.

40 enrolled

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone

NCT03646422 2022-03-31

AEDV Registry of Primary Cutaneous Lymphoma

2,000 enrolled

DermatologicLymphoid

Sezary Syndrome, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Extranodal NK-T-Cell

NCT04952974 2021-07-07

MALYZOMA-II

LymphoidOther hematologic neoplasm

420 enrolled

Leukemia, Hairy Cell, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT04604028 2020-10-27

LCMALT

21 enrolled

Lymphoma, B-Cell, Marginal Zone

NCT02732236 2018-04-18

Marginal Zone Lymphoma Cohort in Korea

500 enrolled

Lymphoma, B-Cell, Marginal Zone

NCT00377195 2018-02-28

Involved Field Radiotherapy for Non-gastric Marginal Zone Lymphoma

79 enrolled

Lymphoma, B-Cell, Marginal Zone

NCT03335098 2017-11-07

BOMB-THROW

15 enrolled

Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone

NCT03265158 2017-08-29

BMPB

108 enrolled

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT03261349 2017-08-25

Antiviral Agent HARVONI® for the Treatment of HCV-associated Indolent B-Cell Lymphoma

21 enrolled

Hepatitis C, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone

NCT02987127 2016-12-08

Prospective Study of Frontline H Pylori Eradication in the Treatment of Early-stage Extragastric MALT Lymphoma

21 enrolled

Lymphoma, B-Cell, Marginal Zone

NCT02388581 2016-03-25

First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCL

30 enrolled

Lymphoma, B-Cell, Marginal Zone

NCT02134262 2014-11-06

Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes

Phase 1/2 Unknown

18 enrolled

Burkitt Lymphoma, Immune System Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphomatoid Granulomatosis, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Experimental, Recurrence, Lymphoma, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Lymphoma, Extranodal NK-T-Cell

NCT01678404 2012-09-05

131I-rituximab for Relapsed or Refractory Marginal Zone B-cell Lymphoma

28 enrolled

Recurrence, Lymphoma, B-Cell, Marginal Zone

NCT00397800 2012-08-28

Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma

Phase 1/2 Unknown

12 enrolled

Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT00935597 2010-10-29

Host Dendritic Cells in Allograft Patients

Phase 1 Unknown

25 enrolled

LymphoidPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Lymphoma, B-Cell, Marginal Zone

NCT00923663 2010-09-28

Trial of Lenalidomide in Patients With Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT) Type

16 enrolled

Lymphoma, B-Cell, Marginal Zone

NCT00927797 2009-06-25

PERLL